Heron Therapeutics reported $86.38M in Operating Expenses for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Alnylam Pharmaceuticals ALNY:US $ 359.99M 93.1M
Amarin AMRN:US 122.94M 5.42M
Ani Pharmaceuticals ANIP:US $ 83.67M 980K
Anika Therapeutics ANIK:US $ 40.25M 4.7M
Arrowhead Research ARWR:US $ 110.25M 19.49M
Eisai 4523:JP Y 211704M 22380M
Emergent Biosolutions EBS:US $ 301.1M 144.7M
Endo International Ordinary Shares ENDP:US $ 583.27M 618.52M
Esperion Therapeutics ESPR:US $ 61.82M 9.2M
GlaxoSmithKline GSK:LN 6.98B 1.65B
Heron Therapeutics HRTX:US $ 86.38M 12.19M
Immunogen IMGN:US $ 60.93M 1.62M
Insmed INSM:US $ 142.94M 12.26M
JAZZ PHA JAZZ:US $ 726.17M 121.18M
Ligand Pharmaceuticals LGND:US $ 53.5M 6.24M
Merk MRK:US $ 10332M 386M
Nektar Therapeutics NKTR:US $ 141.38M 3.46M
Neurocrine Biosciences NBIX:US $ 307.5M 40.8M
Pacira Pharmaceuticals PCRX:US $ 140.6M 14.38M
Regeneron Pharmaceuticals REGN:US $ 1706.6M 605.4M
Sangamo Biosciences SGMO:US $ 73.49M 5.61M
Surmodics SRDX:US $ 31.01M 4.56M
Teva Pharmaceutical Industries TEVA:US 4.37B 352M
Ultragenyx Pharmaceutical RARE:US $ 216.57M 30.61M
Veracyte VCYT:US $ 83.03M 3.36M
Vertex Pharmaceuticals VRTX:US $ 1056.6M 138.24M